| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 896 | 1,270 | 621 | 522 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 896 | 1,270 | 621 | 522 | | | Operating Expenses | | Research Development | 3,747 | 5,028 | 4,905 | 3,698 | | Selling General and Administrative | 3,516 | 4,170 | 3,904 | 3,690 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,367) | (7,927) | (8,188) | (6,866) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,659 | (2,762) | 225 | 13,353 | | Earnings Before Interest And Taxes | (5,373) | (10,689) | (7,962) | 6,487 | | Interest Expense | 1,225 | 1,398 | 1,514 | 1,228 | | Income Before Tax | (6,597) | (12,088) | (9,476) | 5,259 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,597) | (12,088) | (9,476) | 5,259 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,613) | (12,088) | (9,476) | 5,259 | | Preferred Stock And Other Adjustments | (198) | (198) | (198) | (198) | | | Net Income Applicable To Common Shares | ($10,810) | ($12,285) | ($9,674) | $5,061 |
|
0.51% Nasdaq 
Income Statement
